Financhill
Sell
31

CDLX Quote, Financials, Valuation and Earnings

Last price:
$1.20
Seasonality move :
-11.16%
Day range:
$1.05 - $1.24
52-week range:
$0.85 - $4.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.25x
P/B ratio:
1.15x
Volume:
1M
Avg. volume:
815.8K
1-year change:
-68.48%
Market cap:
$64.9M
Revenue:
$278.3M
EPS (TTM):
-$2.10

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CDLX
Cardlytics, Inc.
$54.5M -$0.15 -25.45% -67.28% $1.63
DLPN
Dolphin Entertainment, Inc.
$14M -- 21.78% -- $5.00
LDWY
Lendway, Inc.
-- -- -- -- --
MGNI
Magnite, Inc.
$164.2M $0.20 -0.05% 48.14% $26.86
STGW
Stagwell, Inc.
$729.9M $0.22 3.14% 838.61% $8.25
ZD
Ziff Davis, Inc.
$366.4M $1.78 0.92% 97.21% $43.43
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CDLX
Cardlytics, Inc.
$1.20 $1.63 $64.9M -- $0.00 0% 0.25x
DLPN
Dolphin Entertainment, Inc.
$1.42 $5.00 $17.2M -- $0.00 0% 0.30x
LDWY
Lendway, Inc.
$3.54 -- $6.3M -- $0.00 0% 0.13x
MGNI
Magnite, Inc.
$16.52 $26.86 $2.4B 43.82x $0.00 0% 3.50x
STGW
Stagwell, Inc.
$5.00 $8.25 $1.3B 65.19x $0.00 0% 0.32x
ZD
Ziff Davis, Inc.
$34.72 $43.43 $1.4B 14.06x $0.00 0% 1.04x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CDLX
Cardlytics, Inc.
102.17% 5.847 169.36% 1.05x
DLPN
Dolphin Entertainment, Inc.
77.65% 1.213 190.97% 0.59x
LDWY
Lendway, Inc.
89.4% 1.030 663.79% 0.30x
MGNI
Magnite, Inc.
43.63% 4.652 19.98% 0.99x
STGW
Stagwell, Inc.
70.74% -0.003 123.86% 0.77x
ZD
Ziff Davis, Inc.
32.5% 1.796 56.83% 1.41x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CDLX
Cardlytics, Inc.
$23.6M -$9.7M -40.63% -214.96% -18.63% -$2.7M
DLPN
Dolphin Entertainment, Inc.
$3.2M $308.3K -16% -59.61% 2.08% -$2.4M
LDWY
Lendway, Inc.
-$78K -$3M -5.61% -36.24% -59.05% -$10M
MGNI
Magnite, Inc.
$109.9M $25M 4.2% 7.6% 13.95% $64.6M
STGW
Stagwell, Inc.
$225.2M $45.4M 1.17% 3.8% 6.13% -$55.7M
ZD
Ziff Davis, Inc.
$253.2M $27.9M 4.15% 6.15% 7.68% $108.2M

Cardlytics, Inc. vs. Competitors

  • Which has Higher Returns CDLX or DLPN?

    Dolphin Entertainment, Inc. has a net margin of -139.67% compared to Cardlytics, Inc.'s net margin of -2.47%. Cardlytics, Inc.'s return on equity of -214.96% beat Dolphin Entertainment, Inc.'s return on equity of -59.61%.

    Company Gross Margin Earnings Per Share Invested Capital
    CDLX
    Cardlytics, Inc.
    45.28% -$1.36 $216.7M
    DLPN
    Dolphin Entertainment, Inc.
    21.39% -$0.03 $37.7M
  • What do Analysts Say About CDLX or DLPN?

    Cardlytics, Inc. has a consensus price target of $1.63, signalling upside risk potential of 50.46%. On the other hand Dolphin Entertainment, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 252.11%. Given that Dolphin Entertainment, Inc. has higher upside potential than Cardlytics, Inc., analysts believe Dolphin Entertainment, Inc. is more attractive than Cardlytics, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CDLX
    Cardlytics, Inc.
    0 4 0
    DLPN
    Dolphin Entertainment, Inc.
    0 0 0
  • Is CDLX or DLPN More Risky?

    Cardlytics, Inc. has a beta of 1.094, which suggesting that the stock is 9.352% more volatile than S&P 500. In comparison Dolphin Entertainment, Inc. has a beta of 2.548, suggesting its more volatile than the S&P 500 by 154.846%.

  • Which is a Better Dividend Stock CDLX or DLPN?

    Cardlytics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dolphin Entertainment, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardlytics, Inc. pays -- of its earnings as a dividend. Dolphin Entertainment, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CDLX or DLPN?

    Cardlytics, Inc. quarterly revenues are $52M, which are larger than Dolphin Entertainment, Inc. quarterly revenues of $14.8M. Cardlytics, Inc.'s net income of -$72.7M is lower than Dolphin Entertainment, Inc.'s net income of -$365.5K. Notably, Cardlytics, Inc.'s price-to-earnings ratio is -- while Dolphin Entertainment, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardlytics, Inc. is 0.25x versus 0.30x for Dolphin Entertainment, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CDLX
    Cardlytics, Inc.
    0.25x -- $52M -$72.7M
    DLPN
    Dolphin Entertainment, Inc.
    0.30x -- $14.8M -$365.5K
  • Which has Higher Returns CDLX or LDWY?

    Lendway, Inc. has a net margin of -139.67% compared to Cardlytics, Inc.'s net margin of -65.3%. Cardlytics, Inc.'s return on equity of -214.96% beat Lendway, Inc.'s return on equity of -36.24%.

    Company Gross Margin Earnings Per Share Invested Capital
    CDLX
    Cardlytics, Inc.
    45.28% -$1.36 $216.7M
    LDWY
    Lendway, Inc.
    -1.51% -$1.61 $90.1M
  • What do Analysts Say About CDLX or LDWY?

    Cardlytics, Inc. has a consensus price target of $1.63, signalling upside risk potential of 50.46%. On the other hand Lendway, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cardlytics, Inc. has higher upside potential than Lendway, Inc., analysts believe Cardlytics, Inc. is more attractive than Lendway, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CDLX
    Cardlytics, Inc.
    0 4 0
    LDWY
    Lendway, Inc.
    0 0 0
  • Is CDLX or LDWY More Risky?

    Cardlytics, Inc. has a beta of 1.094, which suggesting that the stock is 9.352% more volatile than S&P 500. In comparison Lendway, Inc. has a beta of 2.643, suggesting its more volatile than the S&P 500 by 164.297%.

  • Which is a Better Dividend Stock CDLX or LDWY?

    Cardlytics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lendway, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardlytics, Inc. pays -- of its earnings as a dividend. Lendway, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CDLX or LDWY?

    Cardlytics, Inc. quarterly revenues are $52M, which are larger than Lendway, Inc. quarterly revenues of $5.2M. Cardlytics, Inc.'s net income of -$72.7M is lower than Lendway, Inc.'s net income of -$3.4M. Notably, Cardlytics, Inc.'s price-to-earnings ratio is -- while Lendway, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardlytics, Inc. is 0.25x versus 0.13x for Lendway, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CDLX
    Cardlytics, Inc.
    0.25x -- $52M -$72.7M
    LDWY
    Lendway, Inc.
    0.13x -- $5.2M -$3.4M
  • Which has Higher Returns CDLX or MGNI?

    Magnite, Inc. has a net margin of -139.67% compared to Cardlytics, Inc.'s net margin of 11.18%. Cardlytics, Inc.'s return on equity of -214.96% beat Magnite, Inc.'s return on equity of 7.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    CDLX
    Cardlytics, Inc.
    45.28% -$1.36 $216.7M
    MGNI
    Magnite, Inc.
    61.24% $0.13 $1.4B
  • What do Analysts Say About CDLX or MGNI?

    Cardlytics, Inc. has a consensus price target of $1.63, signalling upside risk potential of 50.46%. On the other hand Magnite, Inc. has an analysts' consensus of $26.86 which suggests that it could grow by 62.57%. Given that Magnite, Inc. has higher upside potential than Cardlytics, Inc., analysts believe Magnite, Inc. is more attractive than Cardlytics, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CDLX
    Cardlytics, Inc.
    0 4 0
    MGNI
    Magnite, Inc.
    9 1 0
  • Is CDLX or MGNI More Risky?

    Cardlytics, Inc. has a beta of 1.094, which suggesting that the stock is 9.352% more volatile than S&P 500. In comparison Magnite, Inc. has a beta of 2.490, suggesting its more volatile than the S&P 500 by 149.019%.

  • Which is a Better Dividend Stock CDLX or MGNI?

    Cardlytics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Magnite, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardlytics, Inc. pays -- of its earnings as a dividend. Magnite, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CDLX or MGNI?

    Cardlytics, Inc. quarterly revenues are $52M, which are smaller than Magnite, Inc. quarterly revenues of $179.5M. Cardlytics, Inc.'s net income of -$72.7M is lower than Magnite, Inc.'s net income of $20.1M. Notably, Cardlytics, Inc.'s price-to-earnings ratio is -- while Magnite, Inc.'s PE ratio is 43.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardlytics, Inc. is 0.25x versus 3.50x for Magnite, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CDLX
    Cardlytics, Inc.
    0.25x -- $52M -$72.7M
    MGNI
    Magnite, Inc.
    3.50x 43.82x $179.5M $20.1M
  • Which has Higher Returns CDLX or STGW?

    Stagwell, Inc. has a net margin of -139.67% compared to Cardlytics, Inc.'s net margin of 3.21%. Cardlytics, Inc.'s return on equity of -214.96% beat Stagwell, Inc.'s return on equity of 3.8%.

    Company Gross Margin Earnings Per Share Invested Capital
    CDLX
    Cardlytics, Inc.
    45.28% -$1.36 $216.7M
    STGW
    Stagwell, Inc.
    30.41% $0.09 $2.6B
  • What do Analysts Say About CDLX or STGW?

    Cardlytics, Inc. has a consensus price target of $1.63, signalling upside risk potential of 50.46%. On the other hand Stagwell, Inc. has an analysts' consensus of $8.25 which suggests that it could grow by 65%. Given that Stagwell, Inc. has higher upside potential than Cardlytics, Inc., analysts believe Stagwell, Inc. is more attractive than Cardlytics, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CDLX
    Cardlytics, Inc.
    0 4 0
    STGW
    Stagwell, Inc.
    5 2 0
  • Is CDLX or STGW More Risky?

    Cardlytics, Inc. has a beta of 1.094, which suggesting that the stock is 9.352% more volatile than S&P 500. In comparison Stagwell, Inc. has a beta of 1.656, suggesting its more volatile than the S&P 500 by 65.645%.

  • Which is a Better Dividend Stock CDLX or STGW?

    Cardlytics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stagwell, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardlytics, Inc. pays -- of its earnings as a dividend. Stagwell, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CDLX or STGW?

    Cardlytics, Inc. quarterly revenues are $52M, which are smaller than Stagwell, Inc. quarterly revenues of $740.4M. Cardlytics, Inc.'s net income of -$72.7M is lower than Stagwell, Inc.'s net income of $23.8M. Notably, Cardlytics, Inc.'s price-to-earnings ratio is -- while Stagwell, Inc.'s PE ratio is 65.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardlytics, Inc. is 0.25x versus 0.32x for Stagwell, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CDLX
    Cardlytics, Inc.
    0.25x -- $52M -$72.7M
    STGW
    Stagwell, Inc.
    0.32x 65.19x $740.4M $23.8M
  • Which has Higher Returns CDLX or ZD?

    Ziff Davis, Inc. has a net margin of -139.67% compared to Cardlytics, Inc.'s net margin of -0.99%. Cardlytics, Inc.'s return on equity of -214.96% beat Ziff Davis, Inc.'s return on equity of 6.15%.

    Company Gross Margin Earnings Per Share Invested Capital
    CDLX
    Cardlytics, Inc.
    45.28% -$1.36 $216.7M
    ZD
    Ziff Davis, Inc.
    69.63% -$0.09 $2.7B
  • What do Analysts Say About CDLX or ZD?

    Cardlytics, Inc. has a consensus price target of $1.63, signalling upside risk potential of 50.46%. On the other hand Ziff Davis, Inc. has an analysts' consensus of $43.43 which suggests that it could grow by 25.08%. Given that Cardlytics, Inc. has higher upside potential than Ziff Davis, Inc., analysts believe Cardlytics, Inc. is more attractive than Ziff Davis, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CDLX
    Cardlytics, Inc.
    0 4 0
    ZD
    Ziff Davis, Inc.
    2 4 0
  • Is CDLX or ZD More Risky?

    Cardlytics, Inc. has a beta of 1.094, which suggesting that the stock is 9.352% more volatile than S&P 500. In comparison Ziff Davis, Inc. has a beta of 1.469, suggesting its more volatile than the S&P 500 by 46.852%.

  • Which is a Better Dividend Stock CDLX or ZD?

    Cardlytics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ziff Davis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardlytics, Inc. pays -- of its earnings as a dividend. Ziff Davis, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CDLX or ZD?

    Cardlytics, Inc. quarterly revenues are $52M, which are smaller than Ziff Davis, Inc. quarterly revenues of $363.7M. Cardlytics, Inc.'s net income of -$72.7M is lower than Ziff Davis, Inc.'s net income of -$3.6M. Notably, Cardlytics, Inc.'s price-to-earnings ratio is -- while Ziff Davis, Inc.'s PE ratio is 14.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardlytics, Inc. is 0.25x versus 1.04x for Ziff Davis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CDLX
    Cardlytics, Inc.
    0.25x -- $52M -$72.7M
    ZD
    Ziff Davis, Inc.
    1.04x 14.06x $363.7M -$3.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
87
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
60
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock